MetLife, Inc. (MET) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income $1.60B; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income $1.63B; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income $1.65B; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income $1.39B; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | $1.60B | (m) | $724.00M | (m) | (m) | $2.23B* | (m) | (m) | (m) | $256.00M |
| 2026-03-31 | Reported | (m) | $1.63B | (m) | $734.00M | (m) | (m) | $2.69B | (m) | (m) | (m) | $345.00M |
| 2025-09-30 | Reported | (m) | $1.65B | (m) | $621.00M | (m) | (m) | $3.57B* | (m) | (m) | (m) | $308.00M |
| 2025-06-30 | Reported | (m) | $1.39B | (m) | $604.00M | (m) | (m) | $2.19B* | (m) | (m) | (m) | $245.00M |
| 2025-03-31 | Reported | (m) | $1.42B | (m) | $611.00M | (m) | (m) | $4.26B | (m) | (m) | (m) | $404.00M |
| 2024-09-30 | Reported | (m) | $1.44B | (m) | $554.00M | (m) | (m) | $4.17B* | (m) | (m) | (m) | $653.00M |
| 2024-06-30 | Reported | (m) | $1.66B | (m) | $558.00M | (m) | (m) | $3.49B* | (m) | (m) | (m) | $249.00M |
| 2024-03-31 | Reported | (m) | $1.40B | (m) | $577.00M | (m) | (m) | $2.33B | (m) | (m) | (m) | $170.00M |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | $6.14B | (m) | $2.44B | (m) | (m) | $17.09B | (m) | (m) | (m) | $1.26B |
| 2024-12-31 | Reported | (m) | $6.00B | (m) | $2.25B | (m) | (m) | $14.60B | (m) | (m) | (m) | $1.18B |
| 2023-12-31 | Reported | (m) | $5.72B | (m) | $2.23B | (m) | (m) | $13.72B | (m) | (m) | (m) | $560.00M |
| 2022-12-31 | Reported | (m) | $5.98B | (m) | $2.11B | (m) | (m) | $13.04B | (m) | (m) | (m) | $1.06B |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRUDENTIAL FINANCIAL INC (PRU) | United States | $40.974B | 9.56 |
| REINSURANCE GROUP OF AMERICA INC (RGA) | United States | $16.026B | 9.24 |
| Corebridge Financial, Inc. (CRBG) | United States | $15.196B | 14.06 |
| GLOBE LIFE INC. (GL) | United States | $12.862B | 13.60 |
| Jackson Financial Inc. (JXN) | United States | $8.813B | 67.77 |
| Voya Financial, Inc. (VOYA) | United States | $8.705B | 13.49 |
| Primerica, Inc. (PRI) | United States | $8.447B | 18.37 |
| LINCOLN NATIONAL CORP (LNC) | United States | $7.922B | 2.87 |
| GENWORTH FINANCIAL INC (GNW) | United States | $3.574B | 16.92 |
| Brighthouse Financial, Inc. (BHF) | United States | $3.075B | 4.35 |